Clinical trial
Pyronaridine Artesunate (3:1) in Children and Adults With Acute Plasmodium Vivax…
NCT00440999 · Medicines for Malaria Venture, Other · Completed
Key facts
| NCT number | NCT00440999 |
|---|---|
| Title | Pyronaridine Artesunate (3:1) in Children and Adults With Acute Plasmodium Vivax Malaria |
| Official title | A Phase III Comparative (Double-blind, Double-dummy) Randomised Multicentre Study to Assess the Safety & Efficacy of Oral Pyronaridine Artesunate (180:60 mg) Versus Chloroquine (155 mg) in Children & Adult Patients With Acute Vivax Malaria |
| Lead sponsor | Medicines for Malaria Venture, Other |
| Collaborators | Shin Poong Pharmaceuticals Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Malaria |
| Intervention type | Drug |
| Interventions | Pyronaridine artesunate, Chloroquine |
| Enrollment | 456 |
| Start date | Mar 1, 2007 |
| Primary completion | Apr 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Feb 27, 2007 |
| Last update posted | Nov 2, 2021 |
| Countries | Cambodia, India, Indonesia, Thailand |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: